Challenges for the development of mutant isocitrate dehydrogenases 1 inhibitors to treat glioma.
Wang QX, Zhang PY, Li QQ, Tong ZJ, Wu JZ, Yu SP, Yu YC, Ding N, Leng XJ, Chang L, Xu JG, Sun SL, Yang Y, Li NG, Shi ZH.
Wang QX, et al. Among authors: yu yc, yu sp.
Eur J Med Chem. 2023 Sep 5;257:115464. doi: 10.1016/j.ejmech.2023.115464. Epub 2023 May 12.
Eur J Med Chem. 2023.
PMID: 37235998
Review.